Literature DB >> 1466316

Effect of coronary angioplasty on late potentials one to two weeks after acute myocardial infarction.

J D Boehrer1, D B Glamann, R A Lange, J E Willard, W C Brogan, E J Eichhorn, P A Grayburn, A Anwar, L D Hillis.   

Abstract

In survivors of acute myocardial infarction (AMI), the restoration of anterograde flow in the infarct artery, even if accomplished beyond the time for myocardial salvage, may reduce the frequency of subsequent arrhythmic events and sudden death. Twelve subjects (8 men and 4 women, aged 39 to 69 years) with a first AMI, signal-averaged electrocardiographic late potentials, and an occluded infarct artery were prospectively identified. Seven (group I) had successful coronary angioplasty 6 to 15 days after AMI, and 5 (group II) were managed conservatively. Follow-up signal-averaged electrocardiography was performed 3 to 7 months later. From baseline to follow-up, the 7 group I subjects had a significant change in QRS duration (117 +/- 13 [mean + SD] to 102 +/- 10 ms), root-mean-square voltage (10.4 +/- 4.7 to 31.0 +/- 7.6 microV), and low-amplitude signal duration (47.5 +/- 8.5 to 32.4 +/- 5.2 ms) (p < or = 0.05 for all 3 variables). No group I patient had a late potential at follow-up. In contrast, the 5 group II patients showed no change in QRS duration or low-amplitude signal duration from baseline to follow-up, and all 5 had a late potential at follow-up. At follow-up, the root-mean-square voltage was significantly greater and the low-amplitude signal and QRS durations significantly less in group I than in group II (p < 0.05 for all 3 variables). Thus, in our patients, the mechanical restoration of anterograde perfusion in an occluded infarct artery 1 to 2 weeks after AMI caused the resolution of signal-averaged electrocardiographic late potentials.

Entities:  

Mesh:

Year:  1992        PMID: 1466316     DOI: 10.1016/0002-9149(92)90450-d

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  Infarct artery patency and survival following myocardial infarction.

Authors:  L D Hillis; J E Cigarroa; R A Lange
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

2.  Cardioplegia and ventricular late potentials in cardiac surgical patients.

Authors:  N Schütz; J-A Romand; N D Yanez; M M Treggiari; K Bendjelid
Journal:  J Clin Monit Comput       Date:  2011-09-20       Impact factor: 2.502

3.  Benefits of late reperfusion in the treatment of acute myocardial infarction.

Authors:  Kinji Ishikawa
Journal:  J Thromb Thrombolysis       Date:  2002-06       Impact factor: 2.300

4.  Coronary Artery Patency and Survival in Clinical Trials.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

5.  The Open Artery: Electrophysiologic Considerations.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

6.  The Open-Artery Hypothesis: An Overview.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

7.  Significance of perfusion of the infarct related coronary artery for susceptibility to ventricular tachyarrhythmias in patients with previous myocardial infarction.

Authors:  K K Ray
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

Review 8.  The "open artery hypothesis" in survivors of myocardial infarction.

Authors:  W R Pitts; J E Cigarroa; R A Lange; L D Hillis
Journal:  Clin Cardiol       Date:  1997-06       Impact factor: 2.882

9.  Late reopening of an occluded infarct related artery improves left ventricular function and long term clinical outcome.

Authors:  F Piscione; G Galasso; G De Luca; G Marrazzo; G Sarno; O Viola; D Accardo; M Chiariello
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

10.  Is the change of late potential over time related to enzyme levels? Ischemic burden in acute myocardial infarction.

Authors:  Namik Kemal Eryol; Ramazan Topsakal; Abdurrahman Oguzhan; Adnan Abaci; Emrullah Başar; Ali Ergin; Servet Cetin
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.